CLINICAL_TRIALS trial_result · 2012-06-29

Clinical Trial Update: Safety and Efficacy Study of XPF-001 to Treat Pain Following Wisdom Tooth Extraction [Phase 2]

A Phase 2 trial assessed the safety and efficacy of XPF-001 for dental pain following wisdom tooth extraction. Results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Xenon Pharmaceuticals Inc. | Conditions: Dental Pain | Phase 2 | Status: COMPLETED | Results posted: 2012-06-29